Time course of changes in vision-related quality of life following intravitreal ranibizumab treatment for branch retinal vein occlusion

To evaluate the vision-related quality of life (VR-QOL) treated by intravitreal ranibizumab (IVR) in patients with branch retinal vein occlusion (BRVO) and to assess subscale items of the VR-QOL. This was prospective, multicenter, open-label, observational study including 38 patients with unilateral...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Shohei, Okamoto, Fumiki, Murakami, Tomoya, Sugiura, Yoshimi, Hiraoka, Takahiro, Okamoto, Yoshifumi, Oshika, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352694/
https://www.ncbi.nlm.nih.gov/pubmed/35927561
http://dx.doi.org/10.1038/s41598-022-17587-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352694/
https://www.ncbi.nlm.nih.gov/pubmed/35927561
http://dx.doi.org/10.1038/s41598-022-17587-0

Ejemplares similares